Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Here is a review the mechanisms that lead to resistance, including risk factors.
Inequities can include access to care issues that run from prevention to acute treatment. Addressing such issues can lead to better outcomes.
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.
The 340B program has had a great impact on access to HIV treatment and prevention services in the US.
The key is using the right dose on the right patient at the right time.
This unusual Case Study describes a young woman who presented with an acute onset of headaches and dizziness and was found to have aseptic meningitis.
Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.
An assessment of a comparative study between leading options for a burdensome infection.
In the latest article from SIDP, here is a look at the use of various intravenous (IV) antimicrobial therapies to address infections in these patients.
At 7.1%, vitamin C deficiency in the US is rare. Unfortunately, identifying scurvy is complex, frustrating, and time-consuming for both patient and provider.
Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.
Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.
A new study demonstrated that gut organisms can alter drug availability by biotransformation on a significantly broader scale than previously expected.
This time of year means new trainees will begin their careers and are excited to take on research projects. However, they may have limited to no experience in this area. Here is an opportunity to give them structure and guidance when committing to longitudinal trainee research.
Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.
Low-frequency resistant cells in bacterial isolates are challenging to detect and may contribute to unexplained treatment failure.
An expert in infectious diseases reviews best practices for improving personalized medicine when treating complicated urinary tract infections and highlights the importance of antimicrobial stewardship.
Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.
Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.
Hurricane season is accompanied by an uptick in infectious diseases associated with environmental and water exposures.
The broad host range and natural reassortment of the influenza virus has played an instrumental role in previous pandemics, and the virus is poised for future large-scale outbreaks.
With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.
The federal government is working to provide greater access to testing and treatment.
Gonococcal septic polyarthritis is an uncommon manifestation of N gonorrhoeae infection, but has increased by about 40% in recent years.
Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.